Blood markers of brain cell damage higher over short term in COVID-19 patients than in Alzheimer's patients

Patients hospitalized for COVID-19 had higher levels over the short term of blood proteins known to rise with neurological damage than non-COVID-19 patients diagnosed with Alzheimer’s disease, a new study finds.

This article was originally published on MedicalXpress.com

Read More: